315 related articles for article (PubMed ID: 22722466)
1. Expression of matrix metalloproteinase-13 and Ki-67 in nonmelanoma skin cancer in xeroderma pigmentosum and non-xeroderma pigmentosum.
El-Hawary AK; Yassin E; Khater A; Abdelgaber S
Am J Dermatopathol; 2013 Feb; 35(1):45-9. PubMed ID: 22722466
[TBL] [Abstract][Full Text] [Related]
2. Immunohistochemical prognostic criteria in xeroderma pigmentosum.
Karakok M; Turkmen A; Bekerecioglu M; Koçer NE
Int J Dermatol; 2010 Nov; 49(11):1266-71. PubMed ID: 21038547
[TBL] [Abstract][Full Text] [Related]
3. Xeroderma pigmentosum skin: an immune privilege site for tumor development.
Abid K; El Mezni F; Kamoun MR; Fazaa B; Zermani R; Hadouchi C; Hamzaoui K
J Cutan Pathol; 2010 Apr; 37(4):452-9. PubMed ID: 19719835
[TBL] [Abstract][Full Text] [Related]
4. Immunohistochemical expression of sperm-associated antigen 9 in nonmelanoma skin cancer.
Seleit I; Bakry OA; Samaka RM; Malak MA
Am J Dermatopathol; 2015 Jan; 37(1):38-45. PubMed ID: 25033008
[TBL] [Abstract][Full Text] [Related]
5. [Expression and significance of matrix metalloproteinase and tissue inhibitor of matrix metalloproteinase in non-melanoma skin cancer].
Fu XR; Zhang C; Chen CY; Zhang L; Wang LX; Wang BH; Liu XY; Zhang MZ
Zhonghua Zhong Liu Za Zhi; 2012 May; 34(5):369-73. PubMed ID: 22883459
[TBL] [Abstract][Full Text] [Related]
6. Immunohistochemical analysis of TIMP-3 and MMP-9 in actinic keratosis, squamous cell carcinoma of the skin, and basal cell carcinoma.
Poswar FO; Fraga CA; Farias LC; Feltenberger JD; Cruz VP; Santos SH; Silveira CM; de Paula AM; Guimarães AL
Pathol Res Pract; 2013 Nov; 209(11):705-9. PubMed ID: 24011615
[TBL] [Abstract][Full Text] [Related]
7. Immunohistochemical expression of MCM2 in nonmelanoma epithelial skin cancers.
Abdou AG; Elwahed MG; Serag El-Dien MM; Eldien DS
Am J Dermatopathol; 2014 Dec; 36(12):959-64. PubMed ID: 24936676
[TBL] [Abstract][Full Text] [Related]
8. Prevalence of human papillomavirus in skin tumors from repair deficient xeroderma pigmentosum patients.
Luron L; Avril MF; Sarasin A; Daya-Grosjean L
Cancer Lett; 2007 Jun; 250(2):213-9. PubMed ID: 17126994
[TBL] [Abstract][Full Text] [Related]
9. Differential expression of matrix metalloproteinase (MMP)-2, MMP-9 and tissue inhibitor of metalloproteinase (TIMP)-1 and TIMP-2 in non-melanoma skin cancer: implications for tumour progression.
O'Grady A; Dunne C; O'Kelly P; Murphy GM; Leader M; Kay E
Histopathology; 2007 Dec; 51(6):793-804. PubMed ID: 18042068
[TBL] [Abstract][Full Text] [Related]
10. Expression of basement membrane antigens and matrix metalloproteinases 2 and 9 in cutaneous basal and squamous cell carcinomas.
Dumas V; Kanitakis J; Charvat S; Euvrard S; Faure M; Claudy A
Anticancer Res; 1999; 19(4B):2929-38. PubMed ID: 10652575
[TBL] [Abstract][Full Text] [Related]
11. Comparative analysis of immunohistochemical markers with invasiveness and histologic differentiation in squamous cell carcinoma and basal cell carcinoma of the skin.
Son KD; Kim TJ; Lee YS; Park GS; Han KT; Lim JS; Kang CS
J Surg Oncol; 2008 Jun; 97(7):615-20. PubMed ID: 18404670
[TBL] [Abstract][Full Text] [Related]
12. Diagnosing xeroderma pigmentosum group C by immunohistochemistry.
de Feraudy S; Boubakour-Azzouz I; Fraitag S; Berneburg M; Chan L; Chew K; Clericuzio CL; Cunningham B; Tope WD; Cleaver JE
Am J Dermatopathol; 2010 Apr; 32(2):109-17. PubMed ID: 19915453
[TBL] [Abstract][Full Text] [Related]
13. Cancer protection in xeroderma pigmentosum variant (XP-V).
Somos S; Farkas B; Schneider I
Anticancer Res; 1999; 19(3B):2195-9. PubMed ID: 10472330
[TBL] [Abstract][Full Text] [Related]
14. Xeroderma pigmentosum at a tertiary care center in Saudi Arabia.
Alwatban L; Binamer Y
Ann Saudi Med; 2017; 37(3):240-244. PubMed ID: 28578364
[TBL] [Abstract][Full Text] [Related]
15. Differential expression of matrilysin-1 (MMP-7), 92 kD gelatinase (MMP-9), and metalloelastase (MMP-12) in oral verrucous and squamous cell cancer.
Impola U; Uitto VJ; Hietanen J; Hakkinen L; Zhang L; Larjava H; Isaka K; Saarialho-Kere U
J Pathol; 2004 Jan; 202(1):14-22. PubMed ID: 14694517
[TBL] [Abstract][Full Text] [Related]
16. Differential immunohistochemical expression of matrix metalloproteinase-10 (MMP-10) in non-melanoma skin cancers of the head and neck.
Kadeh H; Saravani S; Heydari F; Shahraki S
Pathol Res Pract; 2016 Oct; 212(10):867-871. PubMed ID: 27567711
[TBL] [Abstract][Full Text] [Related]
17. The immunobiology of skin cancer.
Dellon AL; Potvin C; Chretien PB; Rogentine CN
Plast Reconstr Surg; 1975 Mar; 55(3):341-354. PubMed ID: 1078893
[TBL] [Abstract][Full Text] [Related]
18. [Xeroderma pigmentosum: report of 6 cases in Dakar].
Dieng MT; Niang SO; Dangou JM; Ndiaye B
Bull Cancer; 2001 Feb; 88(2):199-202. PubMed ID: 11257594
[TBL] [Abstract][Full Text] [Related]
19. Xeroderma pigmentosum patients belonging to complementation group F and efficient liquid-holding recovery of ultraviolet damage.
Nishigori C; Fujisawa H; Uyeno K; Kawaguchi T; Takebe H
Photodermatol Photoimmunol Photomed; 1991 Aug; 8(4):146-50. PubMed ID: 1814424
[TBL] [Abstract][Full Text] [Related]
20. Functional analysis of novel sonic hedgehog gene mutations identified in basal cell carcinomas from xeroderma pigmentosum patients.
Couvé-Privat S; Le Bret M; Traiffort E; Queille S; Coulombe J; Bouadjar B; Avril MF; Ruat M; Sarasin A; Daya-Grosjean L
Cancer Res; 2004 May; 64(10):3559-65. PubMed ID: 15150112
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]